During the past decade, DIA-MED CENTRUM s.r.o. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "DIA-MED CENTRUM s.r.o." are "Type 2 Diabetes" (2 trials), "Type 2 Diabetes Mellitus" (2 trials), "Diabetes Mellitus, Type 2" (1 trials), "Obesity" (1 trials) and "Overweight" (1 trials). Many other conditions were trialed in "DIA-MED CENTRUM s.r.o." in a lesser frequency.

Most popular intervention types in "DIA-MED CENTRUM s.r.o." are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Dulaglutide" (3 trials), "Tirzepatide" (3 trials), "Placebo" (2 trials), "Insulin Degludec" (1 trials) and "Insulin Efsitora Alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "DIA-MED CENTRUM s.r.o." are 6 trials for "All" genders.

Currently, there are NaN active trials in "DIA-MED CENTRUM s.r.o.". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in DIA-MED CENTRUM s.r.o., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in DIA-MED CENTRUM s.r.o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".